Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lancaster
S Camarata

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
Plos One|November 23, 2013
Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung diseaseJonathan A Kropski, Jason M Pritchett, Wendi R Mason, et al.
Cancer Treatment Reviews|April 17, 2022
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and managementSandra M Swain, Mizuki Nishino, Lisa H Lancaster, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Viral infection in acute exacerbation of idiopathic pulmonary fibrosisSharon Chao Wootton, Dong Soon Kim, Yasuhiro Kondoh, et al.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Chest|November 29, 2016
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical TrialMarilyn K Glassberg, Julia Minkiewicz, Rebecca L Toonkel, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomyHimanshu R Lukka, Stephanie L Pugh, William U Shipley, et al.
Chest|February 17, 2022
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi StudyFranck F Rahaghi, Nicholas A Kolaitis, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society|July 25, 2022
The Association between Exposures and Disease Characteristics in Familial Pulmonary FibrosisCarla R Copeland, Edwin F Donnelly, Mitra Mehrad, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
The European Respiratory Journal|July 2, 2021
Effects of nintedanib by inclusion criteria for progression of interstitial lung diseaseToby M Maher, Kevin K Brown, Michael Kreuter, et al.
Plos One|November 23, 2013
Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung diseaseJonathan A Kropski, Jason M Pritchett, Wendi R Mason, et al.
Cancer Treatment Reviews|April 17, 2022
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and managementSandra M Swain, Mizuki Nishino, Lisa H Lancaster, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
Viral infection in acute exacerbation of idiopathic pulmonary fibrosisSharon Chao Wootton, Dong Soon Kim, Yasuhiro Kondoh, et al.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Chest|November 29, 2016
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical TrialMarilyn K Glassberg, Julia Minkiewicz, Rebecca L Toonkel, et al.
International Journal of Radiation Oncology, Biology, Physics|August 2, 2025
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomyHimanshu R Lukka, Stephanie L Pugh, William U Shipley, et al.
Chest|February 17, 2022
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi StudyFranck F Rahaghi, Nicholas A Kolaitis, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society|July 25, 2022
The Association between Exposures and Disease Characteristics in Familial Pulmonary FibrosisCarla R Copeland, Edwin F Donnelly, Mitra Mehrad, et al.
Pageof 7